Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

380
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
380
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

699
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
699
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.0K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining interstitial lung disease related to idiopathic inflammatory myopathies: a systematic review protocol of the Myositis Clinical Trial Consortium (MCTC).

Systematic reviews·2026
Same author

A 62-Year-Old Woman With Progressive Dyspnea, Interlobular Septal Thickening, and Ground-Glass Opacities.

Chest·2026
Same author

Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis.

Annals of the rheumatic diseases·2026
Same author

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).

Drugs - real world outcomes·2026
Same author

Interstitial pneumonia with autoimmune features: A literature review.

Respiratory medicine·2026
Same author

Distant recurrence from thymoma biopsy seeding: a case report.

Mediastinum (Hong Kong, China)·2026

Related Experiment Video

Updated: Dec 27, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K

Systemic sclerosis-associated interstitial lung disease.

Apostolos Perelas1, Richard M Silver2, Andrea V Arrossi3

  • 1Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA, USA.

The Lancet. Respiratory Medicine
|March 2, 2020
PubMed
Summary
This summary is machine-generated.

Systemic sclerosis (SSc) is an autoimmune disease causing fibrosis, often leading to interstitial lung disease (ILD), the primary cause of death. Current treatments include immunosuppressants, antifibrotics, and for severe cases, transplantation.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

679
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.5K

Related Experiment Videos

Last Updated: Dec 27, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

679
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.5K

Area of Science:

  • Rheumatology
  • Pulmonology
  • Immunology

Background:

  • Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterized by immune dysregulation and progressive fibrosis.
  • It predominantly affects young to middle-aged women, leading to significant morbidity and mortality.
  • Interstitial lung disease (ILD) is the leading cause of death in SSc patients, affecting up to 30% and carrying a 10-year mortality of 40%.

Purpose of the Study:

  • To provide a comprehensive overview of systemic sclerosis-associated interstitial lung disease (SSc-ILD).
  • To discuss the prevalence, risk factors, clinical presentation, and diagnostic patterns of SSc-ILD.
  • To review current and emerging therapeutic strategies for SSc-ILD.

Main Methods:

  • Literature review of systemic sclerosis and interstitial lung disease.
  • Analysis of epidemiological data on SSc-ILD prevalence and mortality.
  • Summary of current treatment guidelines and emerging therapies.

Main Results:

  • SSc-ILD is more prevalent in African Americans and individuals with diffuse cutaneous SSc or anti-topoisomerase 1 antibodies.
  • Common clinical presentations include dyspnea and cough, often with a non-specific interstitial pneumonia pattern on CT scans.
  • Standard therapies involve immunosuppressants like mycophenolate mofetil or cyclophosphamide, supplemented by biological and antifibrotic agents.

Conclusions:

  • Systemic sclerosis-associated interstitial lung disease is a critical determinant of survival in SSc patients.
  • Early recognition and appropriate management are crucial for improving outcomes.
  • While immunosuppressants remain a cornerstone, targeted biological and antifibrotic therapies offer new avenues, with transplantation reserved for refractory cases.